iStent inject® W Trabecular Micro-Bypass System (Model iS2) - Glaucoma micro-stent
ARTG ID: 484205 · RQSolutions Medical Devices Distribution Support · Glaukos Corporation · Class III · Started March 26, 2025
Good Name: RQSolutions Medical Devices Distribution Support - iStent inject® W Trabecular Micro-Bypass System (Model iS2) - Glaucoma micro-stent
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 484205
- Start Date
- March 26, 2025
- Effective Date
- March 26, 2025
- Country
- United States of America
- Address
- 229 Avenida Fabricante, San Clemente, CA, 92672
The iStent inject® W Trabecular Micro-Bypass System (Model iS2) is intended to reduce intraocular pressure in adult patients diagnosed with mild to moderate primary open-angle glaucoma (POAG) currently treated with ocular hypotensive medication. The device can be implanted with or without cataract surgery
Access comprehensive regulatory information for iStent inject® W Trabecular Micro-Bypass System (Model iS2) - Glaucoma micro-stent in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 484205 and sponsored by RQSolutions Medical Devices Distribution Support, manufactured by Glaukos Corporation in United States of America. The device registration started on March 26, 2025.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.